Use of archived specimens in evaluation of prognostic and predictive biomarkers.

New guidelines are proposed that stipulate adequate amounts of archived tissue must be available from enough patients from a prospective trial for analyses to have adequate statistical power and for the patients included in the evaluation to be clearly representative of the patients in the trial.